Steven Cohen’s Eledon Pharmaceuticals ELDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$135K Buy
+53,247
New +$179K ﹤0.01% 3592
2025
Q1
– Sell
-1,095,000
Closed -$4.51M – 2168
2024
Q4
$4.51M Buy
+1,095,000
New +$4.32M 0.01% 984
2022
Q4
– Sell
-375,000
Closed -$1.04M – 1592
2022
Q3
$1.04M Sell
375,000
-53,360
-12% -$170K ﹤0.01% 1051
2022
Q2
$1.04M Sell
428,360
-127,535
-23% -$389K ﹤0.01% 1064
2022
Q1
$2.19M Buy
555,895
+124,460
+29% +$483K 0.01% 863
2021
Q4
$1.9M Buy
431,435
+221,945
+106% +$1.12M 0.01% 829
2021
Q3
$1.3M Buy
209,490
+20,800
+11% +$145K 0.01% 829
2021
Q2
$1.49M Buy
188,690
+63,690
+51% +$601K 0.01% 758
2021
Q1
$1.34M Buy
+125,000
New +$1.89M 0.01% 777

Other funds holding ELDN

Steven Cohen's ELDN Position: Q3 2026 in Review

Steven Cohen opened a new position in Eledon Pharmaceuticals (ELDN) in Q3 2026: 53,247 shares worth $135K. The stake represents ﹤0.01% of the portfolio and ranks #3592 among its holdings. This is a return to the name: Steven Cohen previously reported a position in ELDN as recently as Q4 2024.

Steven Cohen first reported a position in ELDN in Q1 2021 and has held it in 9 quarters since. The position peaked at $4.51M in Q4 2024. 155 funds tracked by Wall St. Rank hold ELDN as of Q3 2026.

  • Steven Cohen held 53,247 shares of Eledon Pharmaceuticals worth $135K as of Q3 2026.
  • Eledon Pharmaceuticals was a new Steven Cohen position in Q3 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #3592 holding.
  • Steven Cohen first reported a position in Eledon Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
  • Steven Cohen's Eledon Pharmaceuticals position peaked at $4.51M in Q4 2024.
  • 155 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.